2[2]Austin HA, Boumpas DT,Vaughan EM, et al. Predicting renal outcomes in serere lupus nephritis:contributions of clinical and histologic data. Kidney Int, 1994, 45: 544.
4[5]Martinelli ER, Pereire LJ, Santos ES. Clinical effects of intermittent cyclophosphamide in severe systemic Lupus erythematosus. Nephron, 1996, 74(2): 313.
3Illei GG, Austin HA , Crane M , et al. Combination therapy with pulsecyclophospham ide plus pulse methylp rednisolone improves longtermrenal outcome without adding toxicity in patients with lupus nephritis. Ann In tern Med,2001,135(4) :248-257.
4Mok CC, Ying KY, Tang S, et al. Predictors and outcome of renal flaresafter successful cyclophospham ide treatment for diffuse proliferative lupus glomerulonephritis. A rth ritis Rheum ,2004,50(8) : 2559-2568.
5Blow JE, Boumpas DT, Fessler BJ,et al. Management of lupus nephritis. Kindneyinternational, 1996,49 ( Supp153 ) :88.
6Illei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclophospha mideplus pulse methylp rednisolone improves long termrenal outcome without adding toxicity in patients with lupus nephritis [ J ]. Ann In tern Med,2001,135 ( 4 ) : 248 - 257.
7Mok CC, Ying KY, Tang S, et al. Predictors and outcome of renal flares after successful cyclophospham ide treatment for diffuse prolifer ative lupus glomerulonephritis [J]. Arthritis R heum,2004, 50(8) : 2559 -2568.
